中国医药科学
中國醫藥科學
중국의약과학
China Medicine and Pharmacy
2015年
18期
68-70
,共3页
异位妊娠%腹腔镜保守治疗%药物治疗
異位妊娠%腹腔鏡保守治療%藥物治療
이위임신%복강경보수치료%약물치료
Ectopic pregnancy%Laparoscopic surgery%Drug therapy
目的:比较输卵管妊娠腹腔镜保守治疗和药物治疗的临床疗效。方法回顾性分析2007年10月~2013年10月来我院妇产科就诊的输卵管妊娠患者共400例,所有患者分为两组,分别给予腹腔镜保守治疗和药物治疗,比较临床疗效。结果与药物治疗组比较,腹腔镜保守治疗组治疗后血HCG、住院时间和盆腔炎发生率明显下降(P<0.05),再次宫内妊娠率、受孕率和输卵管通畅率明显升高(P<0.05),重复性同侧异位妊娠率无明显差异(P>0.05)。结论较药物治疗,腹腔镜保守治疗具有创伤小、住院时间短、受孕率和输卵管通畅率高等优势,推荐临床推广应用。
目的:比較輸卵管妊娠腹腔鏡保守治療和藥物治療的臨床療效。方法迴顧性分析2007年10月~2013年10月來我院婦產科就診的輸卵管妊娠患者共400例,所有患者分為兩組,分彆給予腹腔鏡保守治療和藥物治療,比較臨床療效。結果與藥物治療組比較,腹腔鏡保守治療組治療後血HCG、住院時間和盆腔炎髮生率明顯下降(P<0.05),再次宮內妊娠率、受孕率和輸卵管通暢率明顯升高(P<0.05),重複性同側異位妊娠率無明顯差異(P>0.05)。結論較藥物治療,腹腔鏡保守治療具有創傷小、住院時間短、受孕率和輸卵管通暢率高等優勢,推薦臨床推廣應用。
목적:비교수란관임신복강경보수치료화약물치료적림상료효。방법회고성분석2007년10월~2013년10월래아원부산과취진적수란관임신환자공400례,소유환자분위량조,분별급여복강경보수치료화약물치료,비교림상료효。결과여약물치료조비교,복강경보수치료조치료후혈HCG、주원시간화분강염발생솔명현하강(P<0.05),재차궁내임신솔、수잉솔화수란관통창솔명현승고(P<0.05),중복성동측이위임신솔무명현차이(P>0.05)。결론교약물치료,복강경보수치료구유창상소、주원시간단、수잉솔화수란관통창솔고등우세,추천림상추엄응용。
Objective To compare the clinical efficacies of laparoscopic surgery and drug therapy in treatment of tubal pregnancy.Methods 400 patients diagnosed with tubal pregnancy in our hospital from 2007 to 2013 in the obstetrics and gynecology department were involved in this research. Patients in control group were received drug therapy and patients in observation group were received laparoscopic surgery. The clinical efficacies in the two groups were compared. ResultsCompared with drug therapy group, the hospitalization time, serum human chorionic gonadotropin (HCG) level at discharge and the incidence of pelvic inflammatory in laparoscopic surgery group decreased significantly (P<0.05), the rate of secondary intrauterine pregnancy and tubal patency increased significantly (P<0.05). The rate of secondary ectopic pregnancy decreased, but there was no significant difference (P>0.05).Conclusion Compared with drug therapy, laparoscopic surgery has the advantages of minimal injury, short hospitalization time, high intrauterine pregnancy rate and tubal patency rate, recommend clinical popularization and application.